Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-27 @ 10:51 PM
Study NCT ID:
NCT04287894
Status:
TERMINATED
Last Update Posted:
2024-11-06
First Post:
2019-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment
Sponsor:
The Netherlands Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-24
First Submit QC Date:
None
Study First Post Date:
2020-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-04
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL